We need a combination of new approaches to reduce age disparate sex. And we need new technologies to protect young women.
L’expertise universitaire, l’exigence journalistique
Articles sur Malaria
Affichage de 21 à 40 de 259 articles
Intensified efforts to obtain funding are urgently required to mitigate and reverse the negative impacts of the COVID-19 pandemic on TB.
Addressing the noncommunicable disease pandemic can also mitigate challenges facing people living with HIV and complement efforts against TB.
As the Earth warms up the malaria vector will develop faster, allowing them to breed faster, bite more frequently and expand into formerly unsuitable habitats.
The human population has doubled in 48 years, and worsening climate change has left the world facing serious health risks, from infectious diseases to hunger and heat stress.
There are many reasons that malaria is so persistent in Africa. Four of them are poverty, human movement, resistance and climate change.
Marginalised or minority groups seem to suffer the most from heat-related deaths and disease.
For a malaria vaccine to have an impact, health promotion is key. Awareness campaigns must address safety concerns and emphasise expected positive impacts.
Outpatient visits, screening and diagnostic services, and child immunisation were particularly negatively affected.
One of the oldest and deadliest diseases, malaria caused more than 627,000 deaths in 2020. A new treatment based on a drug initially developed to fight cancer has shown considerable promise.
A malaria vaccine called R21 has shown up to 80% efficacy following a booster dose in young children.
Beitbridge and Musina are two border towns in Zimbabwe and South Africa that see many migrants pass through – with different health needs.
It is estimated that half of world’s population is at risk of being infected by an arbovirus.
The spread of this urban malaria vector species threatens the gains made against malaria and the achievement of malaria elimination.
Of the 20 million people living with sickle cell disease globally, more than 66% are in sub-Saharan Africa.
Certain viruses like dengue and Zika can make their hosts smell tastier to mosquitoes. Luckily, vitamin A and its derivatives may help combat these odor changes.
Molecular research is expensive, but worth it because of the burden of disease that it could relieve.
Artificial lights could trick malaria-transmitting mosquito species that feed nocturnally into behaving as if it’s daytime.
So far, similar medical diagnostics tech has either required time-consuming post processing, or has used parts that prevented it from being integrated into a flat design.
South Africa is one of the few malaria-endemic countries in Africa that did not see a major upsurge in malaria cases caused by COVID-related disruptions.
Les contributeurs les plus fréquents
-
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
-
Medical scientist, National Institute for Communicable Diseases
-
Medical Entomologist at the School of Biological Sciences, University of Nairobi
-
Director of the Jenner Institute, University of Oxford
-
Chief Research Officer, Kenya Medical Research Institute
-
UP ISMC: Project Manager and Coordinator, University of Pretoria
-
Director of Science, Ifakara Health Institute
-
Project Manager, Cambridge Africa, Anglia Ruskin University
-
Professor of Molecular Parasitology and Medicine, St George's, University of London
-
Board Certified Internal Medicine Physician and Public Health Scientist, MidMichigan Health, University of Michigan
-
Co-Director, Institute of Infection, Chair, Immunology & Vaccinology, Imperial College London
-
Director and CEO, Burnet Institute
-
Clinical Associate Professor and Principal Hospital Scientist, University of Sydney
-
Professor in Molecular Parasitology and Genetics, Federal University, Oye Ekiti
-
Scientist, International Centre of Insect Physiology and Ecology
